These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 36125896)

  • 1. H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models.
    Haase S; Banerjee K; Mujeeb AA; Hartlage CS; Núñez FM; Núñez FJ; Alghamri MS; Kadiyala P; Carney S; Barissi MN; Taher AW; Brumley EK; Thompson S; Dreyer JT; Alindogan CT; Garcia-Fabiani MB; Comba A; Venneti S; Ravikumar V; Koschmann C; Carcaboso ÁM; Vinci M; Rao A; Yu JS; Lowenstein PR; Castro MG
    J Clin Invest; 2022 Nov; 132(22):. PubMed ID: 36125896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deposition of onco-histone H3.3-G34W leads to DNA repair deficiency and activates cGAS/STING-mediated immune responses.
    Mancarella D; Ellinghaus H; Sigismondo G; Veselinov O; Kühn A; Goyal A; Hartmann M; Fellenberg J; Krijgsveld J; Plass C; Popanda O; Schmezer P; Bakr A
    Int J Cancer; 2024 Jun; 154(12):2106-2120. PubMed ID: 38353495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Pediatric High-Grade Gliomas.
    Garcia-Fabiani MB; Haase S; Banerjee K; McClellan B; Zhu Z; Mujeeb A; Li Y; Yu J; Kadiyala P; Taher A; Núñez FJ; Alghamri MS; Comba A; Mendez FM; Nicola Candia AJ; Salazar B; Koschmann C; Nunez FM; Edwards M; Qin T; Sartor MA; Lowenstein PR; Castro MG
    bioRxiv; 2023 Jun; ():. PubMed ID: 37398299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a novel antibody to define histone 3.3 G34R mutant brain tumours.
    Haque F; Varlet P; Puntonet J; Storer L; Bountali A; Rahman R; Grill J; Carcaboso AM; Jones C; Layfield R; Grundy RG
    Acta Neuropathol Commun; 2017 Jun; 5(1):45. PubMed ID: 28587626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric Hemispheric High-Grade Gliomas and H3.3-G34 Mutation: A Review of the Literature on Biological Features and New Therapeutic Strategies.
    Bonada M; Pittarello M; De Fazio E; Gans A; Alimonti P; Slika H; Legnani F; Di Meco F; Tyler B
    Genes (Basel); 2024 Aug; 15(8):. PubMed ID: 39202398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STINGing the immune system: lessons learned through a model of G34-mutant pediatric high-grade glioma.
    Hall CP; Cronk JC; Rubens JA
    J Clin Invest; 2022 Nov; 132(22):. PubMed ID: 36377657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant DNA repair reveals a vulnerability in histone H3.3-mutant brain tumors.
    Giacomini G; Piquet S; Chevallier O; Dabin J; Bai SK; Kim B; Siddaway R; Raught B; Coyaud E; Shan CM; Reid RJD; Toda T; Rothstein R; Barra V; Wilhelm T; Hamadat S; Bertin C; Crane A; Dubois F; Forne I; Imhof A; Bandopadhayay P; Beroukhim R; Naim V; Jia S; Hawkins C; Rondinelli B; Polo SE
    Nucleic Acids Res; 2024 Mar; 52(5):2372-2388. PubMed ID: 38214234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor location, but not H3.3K27M, significantly influences the blood-brain-barrier permeability in a genetic mouse model of pediatric high-grade glioma.
    Subashi E; Cordero FJ; Halvorson KG; Qi Y; Nouls JC; Becher OJ; Johnson GA
    J Neurooncol; 2016 Jan; 126(2):243-51. PubMed ID: 26511492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Base-resolution methylomes of gliomas bearing histone H3.3 mutations reveal a G34 mutant-specific signature shared with bone tumors.
    Sangatsuda Y; Miura F; Araki H; Mizoguchi M; Hata N; Kuga D; Hatae R; Akagi Y; Amemiya T; Fujioka Y; Arai Y; Yoshida A; Shibata T; Yoshimoto K; Iihara K; Ito T
    Sci Rep; 2020 Sep; 10(1):16162. PubMed ID: 32999376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SHP2-Mediated Inhibition of DNA Repair Contributes to cGAS-STING Activation and Chemotherapeutic Sensitivity in Colon Cancer.
    Wei B; Xu L; Guo W; Wang Y; Wu J; Li X; Cai X; Hu J; Wang M; Xu Q; Liu W; Gu Y
    Cancer Res; 2021 Jun; 81(12):3215-3228. PubMed ID: 33820798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-Grade Gemistocytic Morphology in H3 G34R-Mutant Gliomas and Concurrent K27M Mutation: Clinicopathologic Findings.
    Morris M; Driscoll M; Henson JW; Cobbs C; Jiang L; Gocke CD; Chen L; Rodriguez FJ
    J Neuropathol Exp Neurol; 2020 Oct; 79(10):1038-1043. PubMed ID: 32954438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Chromatin Dynamics and DNA Repair on Genomic Stability and Treatment Resistance in Pediatric High-Grade Gliomas.
    Pinto L; Baidarjad H; Entz-Werlé N; Van Dyck E
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and clinicopathological features of H3.3 G34-mutant high-grade gliomas: a retrospective study of 411 consecutive glioma cases in a single institution.
    Yoshimoto K; Hatae R; Sangatsuda Y; Suzuki SO; Hata N; Akagi Y; Kuga D; Hideki M; Yamashita K; Togao O; Hiwatashi A; Iwaki T; Mizoguchi M; Iihara K
    Brain Tumor Pathol; 2017 Jul; 34(3):103-112. PubMed ID: 28447171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone H3G34R mutation causes replication stress, homologous recombination defects and genomic instability in
    Yadav RK; Jablonowski CM; Fernandez AG; Lowe BR; Henry RA; Finkelstein D; Barnum KJ; Pidoux AL; Kuo YM; Huang J; O'Connell MJ; Andrews AJ; Onar-Thomas A; Allshire RC; Partridge JF
    Elife; 2017 Jul; 6():. PubMed ID: 28718400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis.
    Chen CCL; Deshmukh S; Jessa S; Hadjadj D; Lisi V; Andrade AF; Faury D; Jawhar W; Dali R; Suzuki H; Pathania M; A D; Dubois F; Woodward E; Hébert S; Coutelier M; Karamchandani J; Albrecht S; Brandner S; De Jay N; Gayden T; Bajic A; Harutyunyan AS; Marchione DM; Mikael LG; Juretic N; Zeinieh M; Russo C; Maestro N; Bassenden AV; Hauser P; Virga J; Bognar L; Klekner A; Zapotocky M; Vicha A; Krskova L; Vanova K; Zamecnik J; Sumerauer D; Ekert PG; Ziegler DS; Ellezam B; Filbin MG; Blanchette M; Hansford JR; Khuong-Quang DA; Berghuis AM; Weil AG; Garcia BA; Garzia L; Mack SC; Beroukhim R; Ligon KL; Taylor MD; Bandopadhayay P; Kramm C; Pfister SM; Korshunov A; Sturm D; Jones DTW; Salomoni P; Kleinman CL; Jabado N
    Cell; 2020 Dec; 183(6):1617-1633.e22. PubMed ID: 33259802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse hemispheric glioma with H3-3B G34R mutation: Expanding the spectrum of histone H3 genes in diffuse hemispheric glioma, H3 G34-mutant.
    Nazem A; Lavezo J; Abdullaev Z; Aldape K; Quezado M; Cimino PJ; Pratt DW; Jenkins RB; Ida CM
    J Neuropathol Exp Neurol; 2023 Dec; 83(1):58-60. PubMed ID: 37878797
    [No Abstract]   [Full Text] [Related]  

  • 17. H3 G34-mutant high-grade glioma.
    Lim KY; Won JK; Park CK; Kim SK; Choi SH; Kim T; Yun H; Park SH
    Brain Tumor Pathol; 2021 Jan; 38(1):4-13. PubMed ID: 32995948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional identity of human neural stem cells determines oncogenic responses to histone H3.3 mutants.
    Bressan RB; Southgate B; Ferguson KM; Blin C; Grant V; Alfazema N; Wills JC; Marques-Torrejon MA; Morrison GM; Ashmore J; Robertson F; Williams CAC; Bradley L; von Kriegsheim A; Anderson RA; Tomlinson SR; Pollard SM
    Cell Stem Cell; 2021 May; 28(5):877-893.e9. PubMed ID: 33631116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating H3F3A K27M and G34R/V somatic mutations in a cohort of pediatric brain tumors of different and rare histologies.
    Oliveira VF; De Sousa GR; Dos Santos AC; Saggioro FP; Machado HR; de Oliveira RS; Tone LG; Valera ET
    Childs Nerv Syst; 2021 Feb; 37(2):375-382. PubMed ID: 32766947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas.
    Fontebasso AM; Schwartzentruber J; Khuong-Quang DA; Liu XY; Sturm D; Korshunov A; Jones DT; Witt H; Kool M; Albrecht S; Fleming A; Hadjadj D; Busche S; Lepage P; Montpetit A; Staffa A; Gerges N; Zakrzewska M; Zakrzewski K; Liberski PP; Hauser P; Garami M; Klekner A; Bognar L; Zadeh G; Faury D; Pfister SM; Jabado N; Majewski J
    Acta Neuropathol; 2013 May; 125(5):659-69. PubMed ID: 23417712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.